MENU
+Compare
KRMD
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$2.27
Change
-$0.02 (-0.87%)
Capitalization
107.88M

KRMD KORU Medical Systems Forecast, Technical & Fundamental Analysis

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies... Show more

KRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for KRMD with price predictions
Apr 16, 2025

KRMD's Indicator enters downward trend

The Aroon Indicator for KRMD entered a downward trend on April 16, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 244 similar instances where the Aroon Indicator formed such a pattern. In of the 244 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where KRMD's RSI Indicator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KRMD just turned positive on April 10, 2025. Looking at past instances where KRMD's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KRMD advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

KRMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.391) is normal, around the industry mean (23.907). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.837) is also within normal values, averaging (42.115).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KRMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
KRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KRMD is expected to report earnings to rise 40.00% to -2 cents per share on April 30

KORU Medical Systems KRMD Stock Earnings Reports
Q1'25
Est.
$-0.03
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.03
Q1'24
Beat
by $0.02
The last earnings report on March 12 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 48.89K shares outstanding, the current market capitalization sits at 107.88M.
A.I. Advisor
published General Information

General Information

a company, which engages in the design, manufacture, and market of proprietary medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
100 Corporate Drive
Phone
+1 845 469-2042
Employees
82
Web
https://www.korumedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

KRMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KRMD has been loosely correlated with NVST. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if KRMD jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRMD
1D Price
Change %
KRMD100%
-0.87%
NVST - KRMD
38%
Loosely correlated
+1.07%
CLPT - KRMD
36%
Loosely correlated
+6.25%
BIO - KRMD
35%
Loosely correlated
-2.87%
ICUI - KRMD
32%
Poorly correlated
-0.34%
RGEN - KRMD
31%
Poorly correlated
-1.59%
More